Free Trial

Eloxx Pharmaceuticals (ELOX) Competitors

Eloxx Pharmaceuticals logo

ELOX vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Eloxx Pharmaceuticals stock or one of its competitors? The main competitors of Eloxx Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Eloxx Pharmaceuticals vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Eloxx Pharmaceuticals (NASDAQ:ELOX) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation.

2.9% of Eloxx Pharmaceuticals shares are held by institutional investors. 20.2% of Eloxx Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Eloxx PharmaceuticalsN/AN/A-$36.06MN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Eloxx Pharmaceuticals N/A N/A N/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Eloxx Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Eloxx Pharmaceuticals Neutral

Summary

Eloxx Pharmaceuticals beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Get Eloxx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELOX vs. The Competition

MetricEloxx PharmaceuticalsBiological Products IndustryMedical SectorNASDAQ Exchange
Market CapN/A$281.95M$5.44B$9.61B
Dividend YieldN/AN/A4.61%4.14%
P/E RatioN/AN/A29.7624.84
Price / SalesN/A462.25449.1298.65
Price / CashN/A22.4436.4258.36
Price / BookN/A8.908.185.64
Net Income-$36.06M-$115.81M$3.26B$265.68M

Eloxx Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELOX
Eloxx Pharmaceuticals
N/AN/AN/AN/A$0.00N/A0.0030Gap Down
High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
-0.9%
N/A+22.0%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+84.9%
N/A-75.5%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.11
-8.3%
N/A+314.3%$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.60
-17.5%
N/A-52.6%$0.00$585.60M0.004Gap Down
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
+2.9%
N/A-35.8%$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.15
-2.6%
N/AN/A$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.02
+19.3%
N/A-96.8%$0.00$199.38M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.03
-12.0%
N/A-83.7%$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:ELOX) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners